Holen Sie sich die Stockscreener-App
7.74
2.31%
0.175
Handel nachbörslich:
7.79
0.05
+0.65%
Schlusskurs vom Vortag:
$7.565
Offen:
$7.44
24-Stunden-Volumen:
643.94K
Relative Volume:
0.62
Marktkapitalisierung:
$316.69M
Einnahmen:
$128.29M
Nettoeinkommen (Verlust:
$-30.69M
KGV:
-9.439
EPS:
-0.82
Netto-Cashflow:
$-27.17M
1W Leistung:
-6.52%
1M Leistung:
-16.86%
6M Leistung:
-46.32%
1J Leistung:
-84.60%
1-Tages-Spanne:
$7.40
$7.765
1-Wochen-Bereich:
$7.40
$8.415
52-Wochen-Spanne:
$6.32
$55.57
Rxsight Inc Stock (RXST) Company Profile
Firmenname
Rxsight Inc
Sektor
Branche
Telefon
949-521-7822
Adresse
100 COLUMBIA STREET, ALISO VIEJO
Vergleichen Sie RXST mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
RXST
Rxsight Inc
|
7.74 | 307.28M | 128.29M | -30.69M | -27.17M | -0.82 |
|
ABT
Abbott Laboratories
|
133.27 | 228.66B | 43.11B | 13.94B | 6.78B | 7.9963 |
|
BSX
Boston Scientific Corp
|
96.24 | 140.69B | 18.49B | 2.50B | 3.49B | 1.6801 |
|
SYK
Stryker Corp
|
370.00 | 139.51B | 23.82B | 2.92B | 4.02B | 7.5574 |
|
MDT
Medtronic Plc
|
96.54 | 122.60B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
73.36 | 42.83B | 5.69B | 1.41B | 577.90M | 6.9828 |
Rxsight Inc Stock (RXST) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-15 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2025-07-10 | Herabstufung | Jefferies | Buy → Hold |
| 2025-07-09 | Herabstufung | BTIG Research | Buy → Neutral |
| 2025-07-09 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2025-07-09 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2025-05-19 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2025-04-15 | Eingeleitet | Piper Sandler | Neutral |
| 2025-04-09 | Herabstufung | UBS | Buy → Neutral |
| 2025-04-04 | Herabstufung | JP Morgan | Overweight → Underweight |
| 2025-04-03 | Herabstufung | BofA Securities | Buy → Underperform |
| 2024-12-20 | Herabstufung | Stifel | Buy → Hold |
| 2024-12-11 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2024-12-06 | Eingeleitet | UBS | Buy |
| 2024-10-29 | Eingeleitet | Jefferies | Buy |
| 2024-08-20 | Bestätigt | Needham | Buy |
| 2024-08-06 | Bestätigt | Needham | Buy |
| 2024-05-07 | Bestätigt | BTIG Research | Buy |
| 2023-12-13 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2023-12-12 | Eingeleitet | Stifel | Buy |
| 2023-12-04 | Eingeleitet | Morgan Stanley | Overweight |
| 2023-04-13 | Eingeleitet | Oppenheimer | Outperform |
| 2022-12-12 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2022-04-08 | Eingeleitet | Needham | Buy |
Alle ansehen
Rxsight Inc Aktie (RXST) Neueste Nachrichten
Is RxSight Inc. stock bottoming outJuly 2025 Reactions & Technical Entry and Exit Alerts - newser.com
Strategies to average down on RxSight Inc.Weekly Profit Summary & Weekly High Conviction Trade Ideas - newser.com
Is RxSight Inc. stock a top momentum playJuly 2025 Sector Moves & Stepwise Entry and Exit Trade Signals - newser.com
Will RxSight Inc. rebound enough to break evenTrade Risk Summary & Short-Term High Return Ideas - newser.com
Relative strength of RxSight Inc. in sector analysis2025 Price Momentum & Fast Exit Strategy with Risk Control - newser.com
Applying Wyckoff theory to RxSight Inc. stockJuly 2025 Market Mood & Verified Technical Trade Signals - newser.com
Combining price and volume data for RxSight Inc.July 2025 Movers & Precise Swing Trade Entry Alerts - newser.com
RxSight Inc. stock trend outlook and recovery pathJuly 2025 PostEarnings & Reliable Momentum Entry Alerts - newser.com
Building trade automation scripts for RxSight Inc.July 2025 Decliners & Capital Efficient Trade Techniques - newser.com
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against RxSight, Inc. (RXST) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire
RxSight Inc. stock trend forecast2025 Trading Volume Trends & Free Weekly Chart Analysis and Trade Guides - newser.com
Lacklustre Performance Is Driving RxSight, Inc.'s (NASDAQ:RXST) 25% Price Drop - simplywall.st
When is the best time to exit RxSight Inc.2025 Investor Takeaways & Weekly High Return Stock Opportunities - newser.com
RxSight, Inc. (RXST) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Candlestick signals on RxSight Inc. stock todayWeekly Investment Recap & Fast Exit and Entry Strategy Plans - newser.com
RxSight's (RXST) Sell (E+) Rating Reaffirmed at Weiss Ratings - MarketBeat
RXSIGHT ALERT: Bragar Eagel & Squire, P.C. is Investigating - GlobeNewswire
Full technical analysis of RxSight Inc. stock2025 Major Catalysts & Daily Volume Surge Trade Alerts - newser.com
What data driven models say about RxSight Inc.’s futureGap Down & Fast Moving Stock Watchlists - newser.com
Bronstein, Gewirtz & Grossman, LLC Encourages RxSight, Inc. (RXST) Investors to Inquire about Securities Investigation - ACCESS Newswire
Can RxSight Inc. stock outperform in 2025 bull marketJuly 2025 Trade Ideas & Technical Entry and Exit Alerts - newser.com
How moving averages guide RxSight Inc. tradingPortfolio Update Report & Free Risk Controlled Daily Trade Plans - newser.com
Can volume confirm reversal in RxSight Inc.Stop Loss & Capital Efficient Trade Techniques - newser.com
Trend analysis for RxSight Inc. this week2025 Growth vs Value & Long-Term Growth Plans - newser.com
Is RxSight Inc. stock entering bullish territory2025 Price Targets & Low Risk Growth Stock Ideas - newser.com
Is RxSight Inc a good long term investmentSwing Trading Ideas & Investment Recommendations You Can Trust - earlytimes.in
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against RxSight, Inc. (RXST) And Encourages Investors to Reach Out - ACCESS Newswire
What drives RxSight Inc stock priceTop Performing Stocks & Outstanding Investment Returns - earlytimes.in
Head to Head Contrast: Monogram Orthopaedics (NASDAQ:MGRM) versus RxSight (NASDAQ:RXST) - Defense World
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against RxSight, Inc. (RXST) And Encourages Stockholders to Reach Out - ACCESS Newswire
Finanzdaten der Rxsight Inc-Aktie (RXST)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.19%
1.27%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):